Cirrus Logic (CRUS) EVP Reports Option Exercises and Planned Sales
Rhea-AI Filing Summary
Jeffrey W. Baumgartner, EVP R&D of Cirrus Logic (CRUS), reported option exercises and matching sales executed under a Rule 10b5-1 plan on 09/17/2025. He exercised 7,308 non-qualified options at $78, 1,000 non-qualified options at $88, and 854 incentive stock options at $78, which resulted in acquisition of those shares. On the same date he sold the matching amounts at $120 per share. Following these transactions his reported beneficial ownership in Cirrus Logic is 14,001 shares. The Form 4 was signed by an attorney-in-fact on 09/18/2025. The filing notes the transactions were made pursuant to a 10b5-1 plan adopted on August 20, 2024, and explains vesting schedules for the exercised options.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine, preplanned insider activity under a 10b5-1 plan; disclosures are timely and transparent.
The Form 4 shows exercises of vested stock options and contemporaneous sales executed under a Rule 10b5-1 plan, which is a standard mechanism to avoid trading-window issues. The filing includes vesting schedule details and the 10b5-1 adoption date, supporting compliance and reducing ambiguity about intent. The post-transaction beneficial ownership of 14,001 shares is clearly reported. This is a governance-positive disclosure practice but not material on its own for company valuation.
TL;DR: Insider exercised in-the-money options and sold shares at a higher market price; transactions appear executed under an established plan.
The report documents exercises at strike prices of $78 and $88 and sales at $120 per share, realizing immediate gross proceeds for the reporting person. The presence of a 10b5-1 arrangement reduces interpretive risk that sales reflect new company-specific information. While the cash flows are personally significant to the insider, the size (14,001 shares retained) is small relative to typical market caps and unlikely to be materially market-moving for investors.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) | 7,308 | $0.00 | -- |
| Exercise | Non-Qualified Stock Option (right to buy) | 1,000 | $0.00 | -- |
| Exercise | Incentive Stock Option (right to buy) | 854 | $0.00 | -- |
| Exercise | Common Stock | 7,308 | $78.00 | $570K |
| Sale | Common Stock | 7,308 | $120.00 | $877K |
| Exercise | Common Stock | 1,000 | $88.00 | $88K |
| Sale | Common Stock | 1,000 | $120.00 | $120K |
| Exercise | Common Stock | 854 | $78.00 | $67K |
| Sale | Common Stock | 854 | $120.00 | $102K |
Footnotes (1)
- This transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 20, 2024. Only vested shares can be exercised under this option. 25% of the shares vested on 3/3/22; the remaining shares vested monthly over the following 36 months so that the option was fully vested and exercisable on 3/3/25. Only vested shares can be exercised under this option. 25% of the shares vested on 3/2/23; the remaining shares will vest monthly over the following 36 months so that the option will be fully vested and exercisable on 3/2/26.
